サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1425000

CNS特異的アンチセンスオリゴヌクレオチド市場：タイプ別、用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測

CNS Specific Antisense Oligonucleotide Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 294 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
CNS特異的アンチセンスオリゴヌクレオチド市場：タイプ別、用途別、国別、地域別-2024-2032年の産業分析、市場規模、市場シェア、予測
出版日: 2024年02月07日
発行: AnalystView Market Insights
ページ情報: 英文 294 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

CNS特異的アンチセンスオリゴヌクレオチド市場規模は2023年に51億1,400万米ドルとなり、2024年から2032年にかけてCAGR 22.5％で拡大する見込みです。

CNS特異的アンチセンスオリゴヌクレオチド市場- 市場力学

中枢神経系疾患の有病率の増加が市場成長を牽引すると予測

CNS特異的アンチセンスオリゴヌクレオチドは、中枢神経系疾患に関与する特定の遺伝子や経路に焦点を当てた、精密医療における標的治療アプローチです。この方法は、広範囲に及ぶ治療と比較して、より効果的で安全な治療選択肢を提供する可能性を秘めています。最近の国連報告によると、世界人口のほぼ6人に1人に当たる約10億人が、アルツハイマー病、パーキンソン病、脳卒中、多発性硬化症、てんかん、片頭痛、脳損傷、神経感染症などの神経疾患に苦しんでいます。悲惨なことに、これらの疾患によって年間約680万人が命を奪われています。さらに、ドラッグデリバリー技術の継続的な進歩と研究開発投資は、市場に有望な成長機会を提供しています。しかし、開発に伴う高コストが市場の成長を阻害する可能性もあります。

CNS特異的アンチセンスオリゴヌクレオチド市場-主要インサイト

弊社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約22.5%のCAGRで毎年成長すると予測されています。

用途別では、オンライン薬局は2023年に最大の市場シェアを示すと予測されました。

地域別では、北米が2023年の売上高をリード

CNS特異的アンチセンスオリゴヌクレオチド市場-セグメンテーション分析：

CNS特異的アンチセンスオリゴヌクレオチドの世界市場は、タイプ、用途、地域に基づいてセグメント化されます。

市場はタイプによって4つに分類される：多発性神経炎治療薬、脊髄性筋萎縮症（SMA）治療薬、ハンチントン病治療薬です。これらの分類には様々な神経疾患が含まれ、中枢神経系に特異的なASOは潜在的な治療介入薬として現在研究中です。医薬品開発の状況は急速に変化する可能性があり、ここに示した情報は変更される可能性があることを認識しておくことが重要です。

市場は用途によって3つのカテゴリーに分けられる：病院薬局、小売薬局、オンライン薬局です。市場は主にオンライン薬局セグメントによって支配されています。これらのデジタル・プラットフォームは、患者が従来の薬局に出向くことなく、神経疾患の治療薬を含む処方箋薬を購入できる便利なソリューションを提供しています。

CNS特異的アンチセンスオリゴヌクレオチド市場-地理的洞察

CNS特異的アンチセンスオリゴヌクレオチド市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東アフリカに地理的に広がっています。これらの地域は、事業活動に関与する国々に基づいてさらに分割されます。市場の成長は、主にアンチセンス医薬品の需要増加とヘルスケア支出の増加により、北米が支配的であると予想されます。北米、特に米国とカナダは、最先端の研究施設、臨床試験能力、強固な規制枠組みなど、高度なヘルスケアインフラを有しています。2021年、米国は国内総生産（GDP）の17.8％をヘルスケアに費やしており、これはOECD諸国の平均の約2倍である、と報告書「U.S. Health Care from a Global Perspective」に記載されています。加えて、特に神経変性疾患のような課題治療に対する高度な治療介入に対する需要の高まりが、CNS特異的アンチセンスオリゴヌクレオチド療法の採用に有利な環境を作り出しています。さらに、送達技術の絶え間ない進歩とCNS特異的アンチセンスオリゴヌクレオチド療法の世界の拡大は、市場に成長機会をもたらす可能性があります。しかし、規制上の課題や安全性への懸念は、市場の成長を阻害する可能性があります。

CNS特異的アンチセンスオリゴヌクレオチド市場-競合情勢：

CNS特異的アンチセンスオリゴヌクレオチド市場の競合情勢は、バイオテクノロジーおよび製薬業界において著しい進歩を遂げています。これらの進歩は、疾患関連タンパク質を標的とした革新的な戦略によって推進されてきました。しかし、この分野における新薬の開発には、時間、労力、資源の多大な投資が必要です。したがって、CNS特異的アンチセンスオリゴヌクレオチドの市場開拓において、各社が利用している技術的プラットフォームを評価することは、市場にとって極めて重要です。この評価では、送達方法、標的特異性、新規技術などの要素が極めて重要な役割を果たします。承認された核酸治療薬の数が増えていることは、インビボで遺伝子の設計図を標的とすることによって病気を治療する可能性をさらに強調しています。主にタンパク質に焦点を当てた従来の治療法とは異なり、これらの治療法は疾患の根本的な原因に対処できるという利点があります。この市場で注目すべきプレーヤーは、RNA治療薬を専門とするバイオテクノロジー企業、ウェーブ・ライフ・サイエンシズ社です。ウェーブ社は、中枢神経系に特異的なアンチセンス・オリゴヌクレオチドにパイプラインを特化しており、その技術プラットフォームと差別化戦略を分析することが不可欠です。

最近の進歩

2023年10月、バイオジェン社は、軽度アルツハイマー病におけるタウを標的としたアンチセンスオリゴヌクレオチド治療薬BIIB080の新たなフェーズ1b臨床データを発表しました。本データは、脳脊髄液中のタウ蛋白レベルの低下や、異なる脳領域にわたるタウPET（陽電子放射断層撮影）の結果に基づいており、アルツハイマー病患者の認知機能や日常生活における有望な動向を示しています。

目次

第1章 CNS特異的アンチセンスオリゴヌクレオチド市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 CNS特異的アンチセンスオリゴヌクレオチドの主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 CNS特異的アンチセンスオリゴヌクレオチド産業の研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 CNS特異的アンチセンスオリゴヌクレオチド市場：COVID-19の影響分析

  • プレ新型コロナウイルス感染症の影響分析
  • ポスト新型コロナウイルス感染症の影響分析

第6章 CNS特異的アンチセンスオリゴヌクレオチド市場情勢

  • CNS特異的アンチセンスオリゴヌクレオチド市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 CNS特異的アンチセンスオリゴヌクレオチド市場：タイプ別

  • 概要
    • タイプ別セグメントシェア分析
    • 多発性神経障害の治療
    • 脊髄性筋萎縮症（SMA）の治療
    • ハンチントン病の治療

第8章 CNS特異的アンチセンスオリゴヌクレオチド市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第9章 CNS特異的アンチセンスオリゴヌクレオチド市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析：CNS特異的アンチセンスオリゴヌクレオチド産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Akcea Therapeutics, Inc.
    • Ionis Pharmaceuticals Inc.
    • Biogen Inc.
    • Sarepta Therapeutics
    • Wave Life Sciences Ltd.
    • Dynacure
    • ProQR Therapeutics NV
    • Stroke Therapeutic Inc.

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE CNS Specific Antisense Oligonucleotide Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global CNS Specific Antisense Oligonucleotide Market, by Type 2019-2032 (USD Million)
  • TABLE CNS Specific Antisense Oligonucleotide Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global CNS Specific Antisense Oligonucleotide Market, by Application 2019-2032 (USD Million)
  • TABLE CNS Specific Antisense Oligonucleotide Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global CNS Specific Antisense Oligonucleotide Market, by Region 2019-2032 (USD Million)
  • TABLE North America CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE North America CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE North America CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa CNS Specific Antisense Oligonucleotide Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa CNS Specific Antisense Oligonucleotide Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa CNS Specific Antisense Oligonucleotide Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE CNS Specific Antisense Oligonucleotide Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Europe CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Asia Pacific CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Latin America CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE Middle East and Africa CNS Specific Antisense Oligonucleotide Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE Germany CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE India CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE Brazil CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa CNS Specific Antisense Oligonucleotide Market share analysis by country, 2023
  • FIGURE Saudi Arabia CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA CNS Specific Antisense Oligonucleotide Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2200

REPORT HIGHLIGHT

CNS Specific Antisense Oligonucleotide Market size was valued at USD 5,114 Million in 2023, expanding at a CAGR of 22.5% from 2024 to 2032.

CNS-specific antisense oligonucleotides (ASOs) are a specific type of therapeutic agent that have been designed to target and regulate gene expression within the central nervous system. These ASOs are short, single-stranded DNA or RNA molecules that have the ability to selectively bind to complementary RNA sequences. This binding process can result in a range of cellular effects, including the degradation of the targeted RNA or the modulation of its splicing. The development of CNS-specific ASOs holds great promise for the treatment of previously challenging neurological disorders. By offering a targeted approach to modulating gene expression, these molecules have the potential to address the root causes of diseases rather than simply managing their symptoms. The FDA has already approved the use of ASOs for the treatment of ten genetic diseases, and ongoing research is exploring their potential for many more.

CNS Specific Antisense Oligonucleotide Market- Market Dynamics

Increasing Prevalence of CNS Disorders is projected to drive the growth of market

CNS-specific antisense oligonucleotides present a targeted therapeutic approach in precision medicine, focusing on specific genes or pathways implicated in CNS disorders. This method holds the potential to offer more effective and safer treatment alternatives compared to broad-spectrum treatments. According to a recent United Nations report, approximately one billion individuals, accounting for nearly one in six of the global population, suffer from neurological disorders such as Alzheimer's disease, Parkinson's disease, strokes, multiple sclerosis, epilepsy, migraines, brain injuries, and neuroinfections. Tragically, these maladies claim the lives of approximately 6.8 million people annually. Moreover, ongoing advancements in drug delivery technologies and research and development investments offer promising growth opportunities for the market. However, the high costs associated with development may impede market growth.

CNS Specific Antisense Oligonucleotide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 22.5% over the forecast period (2024-2032)

Based on Application segmentation, Online Pharmacies was predicted to show maximum market share in the year 2023

On the basis of region, North America was the leading revenue generator in 2023

CNS Specific Antisense Oligonucleotide Market- Segmentation Analysis:

The Global CNS Specific Antisense Oligonucleotide Market is segmented on the basis of Type, Application, and Region.

The market is segmented into four classifications according to Type: Polyneuropathy Treatment, Spinal Muscular Atrophy (SMA) Treatment, and Huntington's disease Treatment. These classifications encompass various neurological conditions, and CNS-specific ASOs are currently under investigation as potential therapeutic interventions. It is crucial to acknowledge that the landscape of drug development can undergo rapid changes, and the information presented here may be subject to alteration.

The market is divided into three categories based on application: Hospital Pharmacies, Retail Pharmacies and Online Pharmacies. The market is predominantly controlled by the Online Pharmacies segment. These digital platforms offer a convenient solution for patients to purchase prescription medications, including those used to treat neurological disorders, without the need to physically visit a traditional pharmacy.

CNS Specific Antisense Oligonucleotide Market- Geographical Insights

CNS Specific Antisense Oligonucleotide market is geographically widespread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the increasing demand for antisense drugs and rising healthcare expenditure. North America, particularly the United States and Canada, has advanced healthcare infrastructure, including state-of-the-art research facilities, clinical trial capabilities, and a robust regulatory framework. In 2021, the U.S. spent 17.8 percent of its gross domestic product (GDP) on healthcare, which is nearly twice the average of OECD countries, as stated in the report U.S. Health Care from a Global Perspective. Additionally, the growing demand for advanced therapeutic interventions, especially for the treatment of challenging conditions like neurodegenerative disorders, creates a favorable environment for the adoption of CNS-specific antisense oligonucleotide therapies. Furthermore, the continuous advancements in delivery technologies and the global expansion of CNS-specific antisense oligonucleotide therapies may provide growth opportunities for the market. However, regulatory challenges and safety concerns could potentially hinder the market's growth.

CNS Specific Antisense Oligonucleotide Market- Competitive Landscape:

The competitive landscape of the CNS-Specific Antisense Oligonucleotide Market has witnessed significant advancements in the biotechnology and pharmaceutical industry. These advancements have been driven by innovative strategies aimed at targeting disease-related proteins. However, the development of new drugs in this field requires a substantial investment of time, effort, and resources. Therefore, it is crucial for the market to evaluate the technological platforms utilized by different companies in the development of CNS-specific antisense oligonucleotides. Factors such as delivery methods, targeting specificity, and novel technologies play a pivotal role in this assessment. The increasing number of approved nucleic acid therapeutics further emphasizes the potential of treating diseases by targeting their genetic blueprints in vivo. Unlike conventional treatments that primarily focus on proteins, these therapeutics offer the advantage of addressing the underlying causes of diseases. One notable player in this market is Wave Life Sciences, a biotechnology company specializing in RNA therapeutics. Wave has dedicated its pipeline to CNS-specific antisense oligonucleotides, making it essential to analyze their technology platform and differentiation strategies within this context.

Recent advancements:

In October 2023, Biogen Inc. announced new Phase 1b clinical data for BIIB080, an investigational antisense oligonucleotide therapy targeting tau in mild Alzheimer's disease. The data showed promising trends in cognition and daily activities among patients with Alzheimer's disease, building upon previous results that demonstrated a reduction in tau protein levels in the cerebral spinal fluid and tau positron emission tomography across different brain regions.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Akcea Therapeutics, Inc.

Ionis Pharmaceuticals Inc.

Biogen Inc.

Sarepta Therapeutics

Wave Life Sciences Ltd.

Dynacure

ProQR Therapeutics N.V.

Stroke Therapeutic Inc.

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polyneuropathy Treatment
  • Spinal Muscular Atrophy (SMA) Treatment
  • Huntington's Disease Treatment

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL CNS SPECIFIC ANTISENSE OLIGONUCLEOTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. CNS Specific Antisense Oligonucleotide Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. CNS Specific Antisense Oligonucleotide Market Snippet by Type
    • 2.1.2. CNS Specific Antisense Oligonucleotide Market Snippet by Application
    • 2.1.3. CNS Specific Antisense Oligonucleotide Market Snippet by Country
    • 2.1.4. CNS Specific Antisense Oligonucleotide Market Snippet by Region
  • 2.2. Competitive Insights

3. CNS Specific Antisense Oligonucleotide Key Market Trends

  • 3.1. CNS Specific Antisense Oligonucleotide Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. CNS Specific Antisense Oligonucleotide Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. CNS Specific Antisense Oligonucleotide Market Opportunities
  • 3.4. CNS Specific Antisense Oligonucleotide Market Future Trends

4. CNS Specific Antisense Oligonucleotide Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. CNS Specific Antisense Oligonucleotide Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. CNS Specific Antisense Oligonucleotide Market Landscape

  • 6.1. CNS Specific Antisense Oligonucleotide Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. CNS Specific Antisense Oligonucleotide Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Polyneuropathy Treatment
    • 7.1.3. Spinal Muscular Atrophy (SMA) Treatment
    • 7.1.4. Huntington's Disease Treatment

8. CNS Specific Antisense Oligonucleotide Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharmacies
    • 8.1.4. Online Pharmacies

9. CNS Specific Antisense Oligonucleotide Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. CNS Specific Antisense Oligonucleotide Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- CNS Specific Antisense Oligonucleotide Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Akcea Therapeutics, Inc.
    • 10.2.2. Ionis Pharmaceuticals Inc.
    • 10.2.3. Biogen Inc.
    • 10.2.4. Sarepta Therapeutics
    • 10.2.5. Wave Life Sciences Ltd.
    • 10.2.6. Dynacure
    • 10.2.7. ProQR Therapeutics N.V.
    • 10.2.8. Stroke Therapeutic Inc.

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us